CARGO Total Liab from 2010 to 2024

CRGX Stock   15.73  0.09  0.57%   
CARGO Therapeutics, Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities will likely drop to about 35.9 M in 2024. Total Liabilities is the total amount of all liabilities that CARGO Therapeutics, Common has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
47.6 M
Current Value
35.9 M
Quarterly Volatility
16 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CARGO Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CARGO Therapeutics,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 2.4 M or Selling General Administrative of 22 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.47. CARGO financial statements analysis is a perfect complement when working with CARGO Therapeutics, Valuation or Volatility modules.
  
Check out the analysis of CARGO Therapeutics, Correlation against competitors.

Latest CARGO Therapeutics,'s Total Liab Growth Pattern

Below is the plot of the Total Liab of CARGO Therapeutics, Common over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. CARGO Therapeutics,'s Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CARGO Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

CARGO Total Liab Regression Statistics

Arithmetic Mean12,342,662
Geometric Mean7,280,431
Coefficient Of Variation129.97
Mean Deviation12,261,860
Median4,679,000
Standard Deviation16,041,484
Sample Variance257.3T
Range43M
R-Value0.68
Mean Square Error150T
R-Squared0.46
Significance0.01
Slope2,428,977
Total Sum of Squares3602.6T

CARGO Total Liab History

202435.9 M
202347.6 M
202245.5 M

About CARGO Therapeutics, Financial Statements

CARGO Therapeutics, investors use historical fundamental indicators, such as CARGO Therapeutics,'s Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CARGO Therapeutics,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities47.6 M35.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CARGO Stock Analysis

When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.